The cost of diabetes care-an elephant in the room

Riddle, Matthew C.; Herman, William H.

doi:10.2337/dci18-0012

Cited by 191Health Systems, Economic Evaluations, Quality of LifeHealthcare Policy and ManagementDiabetes Management and Research

The cost of diabetes care-an elephant in the room

Riddle, Matthew C., Herman, William H.·2018·Diabetes Care

DOI 10.2337/dci18-0012

Open this paper in CoChat — free account

Abstract

Everyone dealing with health care today knows there is an elephant in the room, impossible to miss but frequently ignored—the cost of diabetes care. Although clinicians and scientists may wish to neglect the financial side of diabetes care and focus on less contentious and more familiar matters, this option is no longer viable. For people with diabetes and their families, the elephant stands in the way every day, and for those who plan health services and payment, it is a major concern. Fortunately, the scientific methods used in epidemiologic, clinical, and health services research can be applied to the economics of diabetes care. Collecting observations, identifying patterns, forming hypotheses, and prospectively testing the hypotheses can be just as relevant when one of the variables examined is the cost of care. It is the mission of Diabetes Care to present the best scientific studies related to diabetes. This issue of Diabetes Care has a special section focused on the economic impact of diabetes, including studies designed to understand it and to assess potential solutions. The American Diabetes Association (ADA) has previously reported the costs of diabetes in the U.S. for the years 2002 (1), 2007 (2), and 2012 (3). This issue of Diabetes Care includes a 2017 update (4). Because the methods used in these analyses are similar, comparisons are possible. The most noteworthy findings from the current report are the continuing increase and the remarkable magnitude of the tot…

Integrity signals

Registry

Crossref · 10.2337/dci18-0012

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Costs for noninsulin and insulin diabetes medications have increased dramatically over the past two decades.
“Costs for noninsulin and insulin diabetes medications have increased dramatically over the past two decades, and an increasing proportion of cost is now passed on to people with diabetes and their families (194).”
From 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025 (2025) · cites this paper as [194]
An increasing proportion of diabetes medication costs is now passed on to people with diabetes and their families.
“Costs for noninsulin and insulin diabetes medications have increased dramatically over the past two decades, and an increasing proportion of cost is now passed on to people with diabetes and their families (194).”
From 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025 (2025) · cites this paper as [194]

Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147 · see citing works
Economic Costs of Diabetes in the U.S. in 2017
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dci18-0007 · Cited by 2,528 · see citing works
Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold
Neumann, P. J., Cohen, J. T., & Weinstein, M. C. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1405158 · Cited by 2,249 · see citing works
Economic Costs of Diabetes in the U.S. in 2012
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc12-2625 · Cited by 2,159 · see citing works
Economic costs of diabetes in the U.S. in 2007
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-9017 · Cited by 1,323 · see citing works
Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030
Bommer, C., Sagalova, V., Heesemann, E., Manne‐Goehler, J., Atun, R. A., Bärnighausen, T., Davies, J. I., & Vollmer, S. (2018) · Diabetes Care · doi:10.2337/dc17-1962 · Cited by 1,137 · see citing works
Economic Costs of Diabetes in the U.S. in 2007
Leahy, J. L. (2008) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)79219-9 · Cited by 781 · see citing works
Economic Costs of Diabetes in the U.S. in 2002Preprint
Dall, T. M., Nikolov, P., & Hogan, P. F. (2003) · RePEc: Research Papers in Economics · Cited by 483 · see citing works
The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention
The Diabetes Prevention Program Research Group (2012) · Diabetes Care · doi:10.2337/dc11-1468 · Cited by 436 · see citing works
A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC's National Diabetes Prevention Program
Ely, E. K., Gruss, S. M., Luman, E. T., Gregg, E. W., Ali, M. K., Nhim, K., Rolka, D. B., & Albright, A. L. (2017) · Diabetes Care · doi:10.2337/dc16-2099 · Cited by 386 · see citing works
Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany
Kähm, K., Laxy, M., Schneider, U., Rogowski, W. H., Lhachimi, S. K., & Holle, R. (2018) · Diabetes Care · doi:10.2337/dc17-1763 · Cited by 141 · see citing works
Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme–Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses—A Population-Based and Propensity-Matched Cohort Study
Wan, E. Y. F., Fung, C. S. C., Jiao, F. F., Yu, E. Y. T., Chin, W. Y., Fong, D., Wong, C. K. H., Chan, A. K. C., Chan, K. H. Y., Kwok, R. L. P., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0426 · Cited by 128 · see citing works
Unstable Housing and Diabetes-Related Emergency Department Visits and Hospitalization: A Nationally Representative Study of Safety-Net Clinic Patients
Berkowitz, S. A., Kalkhoran, S. M., Edwards, S. T., Essien, U. R., & Baggett, T. P. (2018) · Diabetes Care · doi:10.2337/dc17-1812 · Cited by 93 · see citing works
Metformin Prescription for Insured Adults With Prediabetes From 2010 to 2012: A Retrospective Cohort Study
Moin, T., Li, J., Duru, O. K., Ettner, S., Turk, N., Keckhafer, A., Ho, S., & Mangione, C. M. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1773 · Cited by 90 · see citing works
The Productivity Burden of Diabetes at a Population Level
Magliano, D. J., Martin, V. J., Owen, A. J., Zomer, E., & Liew, D. (2018) · Diabetes Care · doi:10.2337/dc17-2138 · Cited by 82 · see citing works
Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation
Herman, W. H., Pan, Q., Edelstein, S. L., Mather, K. J., Perreault, L., Barrett-Connor, E. L., Dabelea, D., Horton, E. S., Kahn, S. E., Knowler, W. C., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1116 · Cited by 80 · see citing works
Self-citation
Five-Year Cost-effectiveness of the Multidisciplinary Risk Assessment and Management Programme–Diabetes Mellitus (RAMP-DM)
Jiao, F. F., Fung, C. S. C., Wan, E. Y. F., Chan, A. K. C., McGhee, S. M., Kwok, R. L. P., & Lam, C. L. K. (2017) · Diabetes Care · doi:10.2337/dc17-1149 · Cited by 67 · see citing works
Effect of High-Deductible Insurance on High-Acuity Outcomes in Diabetes: A Natural Experiment for Translation in Diabetes (NEXT-D) Study
Wharam, J. F., Zhang, F., Eggleston, E., Lu, C. Y., Soumerai, S. B., & Ross‐Degnan, D. (2018) · Diabetes Care · doi:10.2337/dc17-1183 · Cited by 54 · see citing works
Changes in Health Insurance Coverage Under the Affordable Care Act: A National Sample of U.S. Adults With Diabetes, 2009 and 2016
Casagrande, S. S., McEwen, L. N., & Herman, W. H. (2018) · Diabetes Care · doi:10.2337/dc17-2524 · Cited by 52 · see citing works
Self-citation
Declines in the Incidence of Diabetes in the U.S.—Real Progress or Artifact?
Selvin, E., & Ali, M. K. (2017) · Diabetes Care · doi:10.2337/dc16-2442 · Cited by 49 · see citing works
Economic Evaluation of Quality Improvement Interventions Designed to Improve Glycemic Control in Diabetes: A Systematic Review and Weighted Regression Analysis
Nuckols, T. K., Keeler, E. B., Anderson, L., Green, J., Morton, S. C., Doyle, B. J., Shetty, K. D., Arifkhanova, A., Booth, M. S., Shanman, R., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1495 · Cited by 39 · see citing works
The National Diabetes Education Program at 20 Years: Lessons Learned and Plans for the Future
Siminerio, L. M., Albright, A. L., FRADKIN, J. E., Gallivan, J. M., McDivitt, J., Rodríguez, B., Tuncer, D. M., & Wong, F. L. (2018) · Diabetes Care · doi:10.2337/dc17-0976 · Cited by 38 · see citing works
The Changing Tides of the Type 2 Diabetes Epidemic—Smooth Sailing or Troubled Waters Ahead? Kelly West Award Lecture 2016
Gregg, E. W. (2017) · Diabetes Care · doi:10.2337/dci16-0055 · Cited by 25 · see citing works
Impact of CMS Competitive Bidding Program on Medicare Beneficiary Safety and Access to Diabetes Testing Supplies: A Retrospective, Longitudinal Analysis
Puckrein, G. A., Nunlee‐Bland, G., Zangeneh, F., Davidson, J. A., Vigersky, R. A., Xu, L., Parkin, C. G., & Marrero, D. G. (2016) · Diabetes Care · doi:10.2337/dc15-1264 · Cited by 22 · see citing works
Trends in Diabetes-Related Preventable Hospitalizations in the U.S., 2005–2014
Rubens, M., Saxena, A., Ramamoorthy, V., Khera, R., Hong, J. C., Veledar, E., & Nasir, K. (2018) · Diabetes Care · doi:10.2337/dc17-1942 · Cited by 22 · see citing works
Impact of the 2013 National Rollout of CMS Competitive Bidding Program: The Disruption Continues
Puckrein, G. A., Hirsch, I. B., Parkin, C. G., Taylor, B. T., Xu, L., & Marrero, D. G. (2017) · Diabetes Care · doi:10.2337/dc17-0960 · Cited by 5 · see citing works

Flagged first, then by citations

Sorted by citations

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s009 · Cited by 1,555 · see citing works
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s009 · Cited by 972 · see citing works
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s009 · Cited by 914 · see citing works
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s009 · Cited by 851 · see citing works
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Bajaj, M., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s009 · Cited by 728 · see citing works
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s009 · Cited by 662 · see citing works
Resurgence in Diabetes-Related Complications
Gregg, E. W., HORA, I. A., & Benoit, S. R. (2019) · JAMA · doi:10.1001/jama.2019.3471 · Cited by 257 · see citing works
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s009 · Cited by 302 · see citing works
An assessment of machine learning models and algorithms for early prediction and diagnosis of diabetes using health indicators
Chang, V. I. C., Ganatra, M. A., Hall, K., Golightly, L., & Xu, Q. A. (2022) · Healthcare Analytics · doi:10.1016/j.health.2022.100118 · Cited by 116 · see citing works
Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline
Doyle-Delgado, K., Chamberlain, J. J., Shubrook, J. H., Skolnik, N., & Trujillo, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2470 · Cited by 111 · see citing works
Burden and consequences of financial hardship from medical bills among nonelderly adults with diabetes mellitus in the United States.
Caraballo, C., Valero-Elizondo, J., Khera, R., Mahajan, S., Grandhi, G. R., Virani, S. S., Mszar, R., Krumholz, H. M., & Nasir, K. (2020) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.119.006139 · Cited by 104 · see citing works
Use of Antihyperglycemic Medications in U.S. Adults: An Analysis of the National Health and Nutrition Examination Survey
Le, P., Chaitoff, A. M., Misra‐Hebert, A. D., Ye, W., Herman, W. H., & Rothberg, M. B. (2020) · Diabetes Care · doi:10.2337/dc19-2424 · Cited by 83 · see citing works
Self-citation
Negative pressure wound therapy use in diabetic foot syndrome—from mechanisms of action to clinical practice
Borys, S., Hohendorff, J., Frankfurter, C., Kieć‐Wilk, B., & Malecki, M. T. (2019) · European Journal of Clinical Investigation · doi:10.1111/eci.13067 · Cited by 84 · see citing works
National and State-Level Trends in Nontraumatic Lower-Extremity Amputation Among U.S. Medicare Beneficiaries With Diabetes, 2000–2017
Harding, J. L., Andes, L. J., Rolka, D. B., Imperatore, G., Gregg, E. W., Li, Y., & Albright, A. (2020) · Diabetes Care · doi:10.2337/dc20-0586 · Cited by 78 · see citing works
Trends in Rates of Infections Requiring Hospitalization Among Adults With Versus Without Diabetes in the U.S., 2000–2015
Harding, J. L., Benoit, S. R., Gregg, E. W., Pavkov, M. E., & Perreault, L. (2019) · Diabetes Care · doi:10.2337/dc19-0653 · Cited by 77 · see citing works
Risk of malignancy in women with systemic lupus erythematosus.
Dm, S., Manzi, S., Janosky, J. E., Kj, S., Ferri, W. A., Ta, M., & Ramsey‐Goldman, R. (1995) · PubMed · Cited by 71 · see citing works
Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses
Alzaid, A., de Guevara, P. L., Beillat, M., Martin, V. L., & Atanasov, P. Y. (2020) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2020.1782748 · Cited by 70 · see citing works
Burden of disease of type 2 diabetes mellitus: cost of illness and quality of life estimated using the Maastricht Study
Janssen, L. M. M., Hiligsmann, M., Elissen, A., Joore, M. A., Schaper, N. C., Bosma, H., Stehouwer, C. D. A., Sep, S. J. S., Koster, A., Schram, M. T., et al. (2020) · Diabetic Medicine · doi:10.1111/dme.14285 · Cited by 66 · see citing works
Assessment of quality of life and its determinants in type-2 diabetes patients using the WHOQOL-BREF instrument in Bangladesh
Amin, M. F., Bhowmik, B., Rouf, R., Khan, M. I., Tasnim, S. A., Afsana, F., Rouf, R. S. B., Hossain, K. N., Khan, M. A. S., Amin, S. M., et al. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01072-w · Cited by 53 · see citing works
Achievement of Guideline-Recommended Targets in Diabetes Care in China
Zhong, V. W., Yu, D., Zhao, L., Yang, Y., Li, X., Li, Y., Huang, Y., Ding, G., & Wang, H. (2023) · Annals of Internal Medicine · doi:10.7326/m23-0442 · Cited by 52 · see citing works
Improving Quality Outcomes: The Value of Diabetes Care and Education Specialists
Rodriguez, K., Ryan, D., Dickinson, J. K., & Phan, V. (2022) · Clinical Diabetes · doi:10.2337/cd21-0089 · Cited by 54 · see citing works
Dose-dependent effect of supervised aerobic exercise on HbA1c in patients with type 2 diabetes: a meta-analysis of randomized controlled trials.
Jayedi, A., Emadi, A., & Shab-Bidar, S. (2022) · Sports Medicine · doi:10.1007/s40279-022-01673-4 · Cited by 47 · see citing works
US Trends in Hospitalizations for Dialysis-Requiring Acute Kidney Injury in People With Versus Without Diabetes
Harding, J. L., Li, Y., Burrows, N. R., Bullard, K. M., & Pavkov, M. E. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.09.012 · Cited by 46 · see citing works
Social Determinants of Poor Management of Type 2 Diabetes Among the Insured
Patel, M. R. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01354-4 · Cited by 43 · see citing works
Health State Utility Values for Type 2 Diabetes and Related Complications in East and Southeast Asia: A Systematic Review and Meta-Analysis
Mok, C. H., Kwok, H. H. Y., Ng, C. S., Leung, G. M., & Quan, J. (2021) · Value in Health · doi:10.1016/j.jval.2020.12.019 · Cited by 39 · see citing works
National trends in pediatric admissions for diabetic ketoacidosis, 2006–2016
Everett, E. M., Copeland, T. P., Moin, T., & Wisk, L. E. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab287 · Cited by 38 · see citing works
Type 2 diabetes mellitus, its impact on quality of life and how the disease can be managed-a review
Garg, P., & Duggal, N. (2022) · Obesity Medicine · doi:10.1016/j.obmed.2022.100459 · Cited by 50 · see citing works
Maintenance of Enteral ACE2 Prevents Diabetic Retinopathy in Type 1 Diabetes
Prasad, R., Floyd, J. L., Dupont, M., Harbour, A., Adu-Agyeiwaah, Y., Asare‐Bediako, B., Chakraborty, D., Kichler, K., Rohella, A., Calzi, S. L., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.322003 · Cited by 38 · see citing works
The Treatment of Diabetic Retinal Edema with Intravitreal Steroids: How and When
Salvetat, M. L., Pellegrini, F., Spadea, L., Salati, C., Musa, M., Gagliano, C., & Zeppieri, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051327 · Cited by 35 · see citing works
Effects of a 12-Month Intensive Lifestyle Monitoring Program in Predominantly Overweight/Obese Arab Adults with Prediabetes
Wani, K., Alfawaz, H., Alnaami, A. M., Sabico, S., Khattak, M. N. K., Al-Attas, O. S., Alokail, M. S., Alharbi, M., Chrousos, G. P., Kumar, S., et al. (2020) · Nutrients · doi:10.3390/nu12020464 · Cited by 36 · see citing works
Impact of a Community Pharmacist-Delivered Information Program on the Follow-up of Type-2 Diabetic Patients: A Cluster Randomized Controlled Study
Michiels, Y., Bugnon, O., Chicoye, A., Dejager, S., Moisan, C., Allaert, F., Hunault, C., Romengas, L., Méchin, H., & Vergès, B. L. (2019) · Advances in Therapy · doi:10.1007/s12325-019-00957-y · Cited by 33 · see citing works
A comparison of online and offline measurement of exhaled breath for diabetes pre-screening by graphene-based sensor; from powder processing to clinical monitoring prototype
Kalidoss, R., & Umapathy, S. (2019) · Journal of Breath Research · doi:10.1088/1752-7163/ab09ae · Cited by 32 · see citing works
Association between Iron Status and Incident Type 2 Diabetes: A Population-Based Cohort Study
Díaz‐López, A., Iglesias‐Vázquez, L., Pallejà-Millán, M., Rey‐Reñones, C., Flores‐Mateo, G., & Arija, V. (2020) · Nutrients · doi:10.3390/nu12113249 · Cited by 32 · see citing works
Trends and Variations in Emergency Department Use Associated With Diabetes in the US by Sociodemographic Factors, 2008-2017
Uppal, T. S., Chehal, P. K., Fernandes, G. F., HAW, J. S., Shah, M. K., Turbow, S. D., Rajpathak, S. N., Narayan, K. M. V., & Ali, M. K. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.13867 · Cited by 31 · see citing works
Retinal microvascular associations with cardiometabolic risk factors differ by diabetes status: results from the UK Biobank
Tapp, R. J., Owen, C. G., Barman, S. A., Strachan, D. P., Welikala, R. A., Foster, P. J., Whincup, P. H., & Rudnicka, A. R. (2022) · Diabetologia · doi:10.1007/s00125-022-05745-y · Cited by 28 · see citing works
Insulinotropic and antidiabetic properties of Eucalyptus citriodora leaves and isolation of bioactive phytomolecules
Ansari, P., Flatt, P. R., Harriott, P., & Abdel‐Wahab, Y. H. A. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgab030 · Cited by 27 · see citing works
Positioning sulphonylureas in a modern treatment algorithm for patients with type 2 diabetes: Expert opinion from a European consensus panel
Consoli, A., Czupryniak, L., Duarte, R., Jermendy, G., Kautzky‐Willer, A., Mathieu, C., Melo, M., Mosenzon, O., Nobels, F. R. E., Παπάνας, Ν., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14102 · Cited by 25 · see citing works
Efficient and rapid synthesis of ultrathin nickel-metal organic framework nanosheets for the sensitive determination of glucose
Koyappayil, A., Yeon, S.-H., Chavan, S. G., Jin, L., Go, A., & Lee, M. (2022) · Microchemical Journal · doi:10.1016/j.microc.2022.107462 · Cited by 21 · see citing works
The Clinical Application of Mealtime Whey Protein for the Treatment of Postprandial Hyperglycaemia for People With Type 2 Diabetes: A Long Whey to Go
Smith, K., Davies, K. A. B., Stevenson, E., & West, D. J. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.587843 · Cited by 22 · see citing works
Estimating Dietary Intake from Grocery Shopping Data—A Comparative Validation of Relevant Indicators in Switzerland
Wu, J., Fuchs, K., Lian, J., Haldimann, M. L., Schneider, T., Mayer, S., Byun, J., Gassmann, R., Brombach, C., & Fleisch, E. (2021) · Nutrients · doi:10.3390/nu14010159 · Cited by 21 · see citing works
The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type 2 Diabetes and Established Cardiovascular Disease
Ehlers, L. H., Lamotte, M., Monteiro, S. B., Sandgaard, S., Holmgaard, P., Frary, E. C., & Ejskjær, N. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01040-y · Cited by 19 · see citing works
Medical, pharmaceutical, and nutritional applications of 3D-printing technology in diabetes
Amin, R., Marashi, S. M. H., Noori, S. M. R., Alavi, Z., Dehghani, E., Maleki, R., Safdarian, M., Rocky, A., Berizi, E., Alemohammad, S. M. A., et al. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103002 · Cited by 19 · see citing works
Diabetes prevalence among diverse Hispanic populations: considering nativity, ethnic discrimination, acculturation, and BMI
Kamody, R. C., Grilo, C. M., Vásquez, E., & Udo, T. (2021) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-021-01138-z · Cited by 19 · see citing works
Origins of the Crisis in Insulin Affordability and Practical Advice for Clinicians on Using Human Insulin
Luo, J., & Gellad, W. F. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-1286-3 · Cited by 19 · see citing works
Healthcare affordability and effects on mortality among adults with liver disease from 2004 to 2018 in the United States
Ayyala-Somayajula, D., Dodge, J. L., Farias, A. J., Terrault, N. A., & Lee, B. P. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.020 · Cited by 18 · see citing works
Impact of Medicare Continuous Subcutaneous Insulin Infusion Policies in Patients With Type 1 Diabetes
Argento, N. B., Liu, J., Hughes, A. S., & McAuliffe‐Fogarty, A. H. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819838292 · Cited by 18 · see citing works
Glucose Homeostasis, Diabetes Mellitus, and Gender-Affirming Treatment
Milionis, C., Ilias, Ι., Venaki, E., & Koukkou, E. (2023) · Biomedicines · doi:10.3390/biomedicines11030670 · Cited by 17 · see citing works
Ameliorating amyloid aggregation through osmolytes as a probable therapeutic molecule against Alzheimer's disease and type 2 diabetes
Kumari, A., Somvanshi, P., & Grover, A. (2020) · RSC Advances · doi:10.1039/d0ra00429d · Cited by 16 · see citing works
Hospital Readmission and Length-of-Stay Prediction Using an Optimized Hybrid Deep Model
Tavakolian, A., Rezaee, A., Hajati, F., & Uddin, S. (2023) · Future Internet · doi:10.3390/fi15090304 · Cited by 14 · see citing works
Impact of a multi-disciplinary team-based care model for patients living with diabetes on health outcomes: a mixed-methods study
Jacobs, J., Dougherty, A., McCarn, B., Saiyed, N. S., Ignoffo, S., Wagener, C., Miguel, C. S., & Martinez, L. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-11062-4 · Cited by 15 · see citing works
The Endocrine Hospitalist: Enhancing the Quality of Diabetes Care
Zilbermint, M. F. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211007908 · Cited by 14 · see citing works
The Place of Sulfonylureas in Guidelines: Why Are There Differences?
Amod, A. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00811-3 · Cited by 14 · see citing works
Prevalence and Awareness of Stroke and Other Comorbidities Associated with Diabetes in Northwest India
Podder, V., Srivastava, V., Kumar, S., Nagarathna, R., Sivapuram, M. S., Kaur, N., Sharma, K., Singh, A., Malik, N., Anand, A., et al. (2020) · Journal of Neurosciences in Rural Practice · doi:10.1055/s-0040-1709369 · Cited by 13 · see citing works
Acute and chronic diabetes complications associated with self-reported oral health: a retrospective cohort study
Parbhakar, K. K., Rosella, L. C., Singhal, S., & Quiñonez, C. (2020) · BMC Oral Health · doi:10.1186/s12903-020-1054-4 · Cited by 12 · see citing works
Mining the sociome for Health Informatics: Analysis of therapeutic lifestyle adherence of diabetic patients in Twitter
Rodríguez, G. P., Pérez‐Pérez, M., Fdez‐Riverola, F., & Lourenço, A. M. G. (2020) · Future Generation Computer Systems · doi:10.1016/j.future.2020.04.025 · Cited by 12 · see citing works
Primary care management of type 2 diabetes: a comparison of the efficacy and safety of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors
Campos, C., & Unger, J. (2021) · Postgraduate Medicine · doi:10.1080/00325481.2021.1971461 · Cited by 12 · see citing works
A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA
Johansen, P., Hunt, B., Iyer, N. N., Dang‐Tan, T., & Pollock, R. F. (2019) · Advances in Therapy · doi:10.1007/s12325-019-00915-8 · Cited by 12 · see citing works
Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Dipeptidyl Peptidase-4 Inhibitors, and Risk of Hospitalization
Lyu, B., Grams, M. E., Chang, A. R., Inker, L. A., Coresh, J., & Shin, J. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.11.013 · Cited by 12 · see citing works
Retrospective quality improvement study of insulin-induced hypoglycemia and implementation of hospital-wide initiatives
Shelton, C., Demidowich, A. P., Motevalli, M., Sokolinsky, S., MacKay, P., Tucker, C., Abundo, C., Peters, E., Gooding, R., Hackett, M., et al. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211008513 · Cited by 11 · see citing works
Rates and estimated cost of primary care consultations in people diagnosed with type 2 diabetes and comorbidities: A retrospective analysis of 8.9 million consultations
Coles, B., Zaccardi, F., Seidu, S., Gillies, C. L., Davies, M. J., Hvid, C. A., & Khunti, K. K. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14340 · Cited by 11 · see citing works
The Mental Status in Patients with Diabetes Mellitus Admitted to a Diabetes Clinic After Presenting in the Emergency Room: The Application of the SCL-90 Scale
Albai, O., Frandeș, M., Timar, R. Z., Timar, B., Anghel, T., Avram, V. F., & Sima, A. C. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s304904 · Cited by 12 · see citing works
Drug Utilization Study of Antidiabetic Drugs in Patients Attending Geriatric Outpatient Department in Tertiary Care Hospital
Hannan, A., Sinha, S., Ganiyani, M. A., & Pustake, M. V. (2021) · Cureus · doi:10.7759/cureus.17555 · Cited by 11 · see citing works
Reasons for non-participation in a self-care training program for diabetic patients: a qualitative study
Sharifi, T., Javan‐Noughabi, J., Asadi, Z., & Zarqi, M. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-07541-1 · Cited by 11 · see citing works
A Composition of Phytonutrients for Glycemic and Weight Management
Urasaki, Y., & Le, T. T. (2022) · Nutrients · doi:10.3390/nu14183784 · Cited by 11 · see citing works
Bornyl Derivatives of p-(Benzyloxy)Phenylpropionic Acid: In Vivo Evaluation of Antidiabetic Activity
Kuranov, S. O., Luzina, O. A., Khvostov, M. V., Baev, D. S., Kuznetsova, D., Zhukova, N., Vassiliev, P. M., Кочетков, А. Н., Tolstikova, T. G., & Salakhutdinov, N. F. (2020) · Pharmaceuticals · doi:10.3390/ph13110404 · Cited by 11 · see citing works
Oscillatory pattern of glycemic control in patients with diabetes mellitus
Vásquez-Muñoz, M., Arce‐Álvarez, A., von Igel, M., Véliz, C. V., Gonzalo Ruiz-Esquide, S., Ramírez‐Campillo, R., Álvarez, C., Ramírez‐Vélez, R., Crespo, F., Izquierdo, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84822-5 · Cited by 11 · see citing works
What Is Valued Most by Patients With Type 2 Diabetes Mellitus When Selecting Second-Line Antihyperglycemic Medications in China
Liu, S., Liu, J., Yu, Y., Si, L., Tang, C., Liu, Z., & Chen, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.802897 · Cited by 10 · see citing works
Utilizing point-of-care A1c to impact outcomes – can we make it happen in primary care?
Rhyu, J., Lambrechts, S. I., Han, M. A., & Freeby, M. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000700 · Cited by 10 · see citing works
Diabetes Patients’ Acceptance of Injectable Treatment, a Scientometric Analysis
Pantea, I., Roman, N. A., Repanovici, A., & Druguș, D. (2022) · Life · doi:10.3390/life12122055 · Cited by 10 · see citing works
The Use of Mobile Personal Health Records for Hemoglobin A1c Regulation in Patients With Diabetes: Retrospective Observational Study
Seo, D., Park, Y. R., Lee, Y., Kim, J. Y., Park, J., & Lee, J. (2020) · Journal of Medical Internet Research · doi:10.2196/15372 · Cited by 10 · see citing works
Mortalidad por diabetes mellitus y su impacto en la esperanza de vida a los 60 años en México
López, M. G. V., & Pérez, G. J. G. (2021) · Revista de Saúde Pública · doi:10.11606/s1518-8787.20210550032929 · Cited by 10 · see citing works
Optimizing diabetes screening frequencies for at-risk groups
Wu, C.-C., & Suen, S. (2021) · Health Care Management Science · doi:10.1007/s10729-021-09575-z · Cited by 9 · see citing works
Lifestyle intervention reduces risk score for cardiovascular mortality in company employees with pre-diabetes or diabetes mellitus – A secondary analysis of the PreFord randomized controlled trial with 3 years of follow-up
Brinkmann, C. K., Hof, H., Gysan, D.-B., Albus, C., Millentrup, S., Bjarnason‐Wehrens, B., Latsch, J., Herold, G., Wegscheider, K., Heming, C., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1106334 · Cited by 9 · see citing works
The Impact of Expanding Telehealth-Delivered Dietary Interventions on Long-Term Cardiometabolic Health
Li, Y., Zhang, D. “., Rajbhandari‐Thapa, J., Li, W., Chen, Z., Mu, L., Liu, J., & Pagán, J. A. (2021) · Population Health Management · doi:10.1089/pop.2021.0260 · Cited by 9 · see citing works
National Trends in Out-of-Pocket Costs Among U.S. Adults With Diabetes Aged 18–64 Years: 2001–2017
Wang, Y., Park, J., Li, R., Luman, E. T., & Zhang, P. (2021) · Diabetes Care · doi:10.2337/dc20-2833 · Cited by 9 · see citing works
Comparative effect of Fenugreek and Cinnamon on management of newly diagnosed cases of Type-2 Diabetes Mellitus
Ahmad, H., Kashif, S., Afreen, A., Safdar, M., & Ahmed, Z. (2021) · Food Science and Technology · doi:10.1590/fst.47720 · Cited by 8 · see citing works
Changes in excess mortality among adults with diabetes-related end-stage kidney disease: a comparison between the USA and Australia
Harding, J. L., Morton, J. I., Shaw, J. E., Patzer, R. E., McDonald, S. P., & Magliano, D. J. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab315 · Cited by 8 · see citing works
Health care professionals talking: Are services for young adults with type 1 diabetes fit for purpose?
Harris, M., James, S., Perry, L., LOWE, J. M., Dunbabin, J. S., & Steinbeck, K. S. (2019) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13210 · Cited by 7 · see citing works
Does disease management for diabetic nephropathy reduce medical expenditure? Evidence from a three-period difference-in-differences analysis
Kawaguchi, H., Moriyama, M., & Hashimoto, H. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-05297-0 · Cited by 7 · see citing works
Income Inequalities and Risk of Early Rehospitalization for Diabetes, Hypertension and Congestive Heart Failure in the Canadian Working-Age Population
Comeau, E., Leonard, P. S. J., & Gupta, N. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.08.007 · Cited by 7 · see citing works
Examination of an Intergenerational Summer Meal Program for Children and Older Adults
Bruce, J. S., Lien, T. N., George, E., Puri, V., Ramirez, M. R., & Merrell, S. B. (2022) · Journal of Community Health · doi:10.1007/s10900-022-01125-0 · Cited by 7 · see citing works
Use of hospital care among Dutch diabetes patients
de Vries, S. A. G., Bak, J. C. G., Stangenberger, V. A., Wouters, M. W. J. M., Nieuwdorp, M., Sas, T., & Verheugt, C. L. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15105 · Cited by 7 · see citing works
How can we improve the management of individuals with attention deficit hyperactivity disorders and co-occurring cardiometabolic disease?
Larsson, H. (2023) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2023.2279608 · Cited by 7 · see citing works
Immediate and Long-Term Effects of an 8-Week Digital Mental Health Intervention on Adults With Poorly Managed Type 2 Diabetes: Protocol for a Randomized Controlled Trial
Boucher, E., Moskowitz, J. T., Kackloudis, G. M., Stafford, J. L., Kwok, I., & Parks, A. C. (2020) · JMIR Research Protocols · doi:10.2196/18578 · Cited by 6 · see citing works
Topical application of the antimuscarinic pirenzepine increased lower limb nerve fibre density in a phase 2a study in type 2 patients with diabetes with peripheral neuropathy
Sivadasan, A., Fernyhough, P., Calcutt, N. A., Frizzi, K. E., Gardner, K., Hansen, A., Breiner, A., Zochodne, D. W., McInnes, N., Punthakee, Z., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.106055 · Cited by 6 · see citing works
Identifying patient preferences for diabetes care: A protocol for implementing a discrete choice experiment in Samoa
Rivara, A. C., Galárraga, O., Selu, M., Arorae, M. S., Wang, R. M., Faasalele‐Savusa, K., Rosen, R. K., Hawley, N. L., & Viali, S. (2023) · PLoS ONE · doi:10.1371/journal.pone.0295845 · Cited by 6 · see citing works
Continuous Glucose Monitoring in 2018
Bode, B. W., & Battelino, T. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.2502 · Cited by 6 · see citing works
Direct and indirect costs of heart failure in relation to diabetes status - A nationwide study
Bundgaard, J. S., Mogensen, U. M., Christensen, S., Ploug, U. J., Rørth, R., Ibsen, R., Kjellberg, J., & Køber, L. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.05.003 · Cited by 6 · see citing works
Temporal trends in cardiovascular outcomes and costs among patients with type 2 diabetes
Williams, B. A., RAJPURA, J. R., Paprocki, Y., Kumar, N., Voyce, S. J., Brady, J. P., & Chang, A. R. (2023) · American Heart Journal · doi:10.1016/j.ahj.2023.07.012 · Cited by 6 · see citing works
Opportunities and impediments of human pluripotent stem cell-derived islets in the treatment of diabetes
Dadheech, N., Cuesta‐Gomez, N., Jasra, I. T., Verhoeff, K. K., Marfil‐Garza, B. A., Mouhammed, O., & Shapiro, A. M. J. (2022) · Journal of Immunology and Regenerative Medicine · doi:10.1016/j.regen.2022.100064 · Cited by 6 · see citing works
Big Topics for Diabetes Care in 2018: Clinical Guidelines, Costs of Diabetes, and Information Technology
Riddle, M. C., Bakris, G. L., Boulton, A. J. M., Blonde, L., D’Alessio, D. A., Greene, E. L., de Groot, M., Hood, K. K., Hu, F. B., Kahn, S. E., et al. (2018) · Diabetes Care · doi:10.2337/dci18-0035 · Cited by 6 · see citing works
Self-citation
Piloting a new compensation model for endocrinologists to improve diabetes care
Alkhaddo, J. B., Bhargava, A., Rossi, C., Custodio, P. J. P., Bononi, P. L., Kramer, E., & Stanescu, I. W. (2022) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2022.100071 · Cited by 5 · see citing works
The 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema: An Expert Consensus
Kolomeyer, A. M., Eichenbaum, D. A., Kiernan, D. F., Suñer, I. J., & Hariprasad, S. M. (2023) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20230215-01 · Cited by 5 · see citing works
Clinical Trials with Stem Cell-Derived Insulin-Producing Cells
Lei, J., & Markmann, J. F. (2023) · Springer eBooks · doi:10.1007/978-3-031-41943-0_23 · Cited by 5 · see citing works
Association of dietary intake, medication and anthropometric indices with serum levels of advanced glycation end products, caspase-3, and matrix metalloproteinase-9 in diabetic patients
Foroumandi, E., Kheirouri, S., Nosrati, R., & Ghodsi, R. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00803-5 · Cited by 5 · see citing works
Facebook as a Medium for the Support and Enhancement of Ambulatory Care for People With Diabetes: Qualitative Realist Evaluation of a Real-World Trial
Cleal, B. R., Willaing, I., Høybye, M. T., & Thomsen, H. H. (2020) · JMIR Diabetes · doi:10.2196/18146 · Cited by 5 · see citing works
3,4′,5-Trimethoxy- trans -stilbene ameliorates hepatic insulin resistance and oxidative stress in diabetic obese mice through insulin and Nrf2 signaling pathways
Tan, Y. L., Zhou, C., Miao, L., Zhang, X., Khan, H. Z., Xu, B., & Cheang, W. S. (2024) · Food & Function · doi:10.1039/d3fo04158a · Cited by 4 · see citing works
Does the encounter type matter when defining diabetes complications in electronic health records?
Hong, D., Shen, Y., Monnette, A., Liu, S., Shao, H., Nauman, E., Price-Haywood, E., Hu, G., & Shi, L. (2020) · Medical Care · doi:10.1097/mlr.0000000000001297 · Cited by 4 · see citing works
Trends in inpatient admissions and emergency department visits for heart failure in adults with versus without diabetes in the USA, 2006–2017
Harding, J. L., Benoit, S. R., HORA, I. A., Sridharan, L., Ali, M. K., Jagannathan, R., Patzer, R. E., & Narayan, K. M. V. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002377 · Cited by 4 · see citing works
Efficacy and safety of insulin detemir versus glargine in patients with diabetes: a systematic review and meta-analysis
Rezaei, S., Taheri, A., Taheri, S., Kasirzadeh, S., Fatemi, B., & Sorato, M. M. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2078700 · Cited by 4 · see citing works

Authors: Riddle, M. C., & Herman, W. H.
Affiliations: Oregon Health & Science University (US)
University of Michigan (US)
Corresponding author: Riddle, Matthew C.
ORCID: Riddle, Matthew C.
Herman, William H.
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 2018-04-12
Volume: 41
Issue: 5
Pages: 929-932
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/dci18-0012
OpenAlex: W2801768830
Cited by: 191
References: 26
Citations by year: 2026: 2 · 2025: 10 · 2024: 23 · 2023: 32 · 2022: 31 · 2021: 37 · 2020: 39 · 2019: 14 · 2018: 2
FWCI: 35.03
Type: journal article
Language: en
Open access: closed
Licence: www.diabetesjournals.org/content/license (vor, 8 d)
Locations: Diabetes Care (publishedVersion)
PubMed (publishedVersion)
Topics: Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords: diabetes care costs, economic burden of diabetes, health care expenditure, health care payment, health planning

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The cost of diabetes care-an elephant in the room

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks